CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Sino Biopharmaceutical Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Sino Biopharmaceutical Ltd
Unit 09, 41F, Office Tower
Convention Plaza, No. 1 Harbour Road
Phone: +852 28029886p:+852 28029886 Hong Kong Ticker: 11771177
Business Summary
Sino Biopharmaceutical Limited is an investment holding company principally engaged in the medicine products business. The Company operates through three business segments. The Modernized Chinese Medicine and Chemical Medicine segment is engaged in the manufacture, sale and distribution of modernized Chinese medicine products and western medicine products. The Investment segment is principally engaged in the long term and short term investments. The Other segment is principally engaged in the related medical and hospital business.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
12/31/202312/31/2022Yes----

Industries
SIC Code Description
2834 Pharmaceutical preparations
8731 Commercial physical and biological research
6799 Investors, not elsewhere classified
6719 Offices of holding companies, not elsewhere classified

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Executive Chairwoman of the Board Y YTse 30 6/30/2015 6/30/2015
Chief Executive Officer, Executive Director S. Y.Tse 27 7/28/2022 10/23/2019
Executive Vice Chairwoman of the Board Cheung LingCheng 58 4/10/2017 1/13/2005
12 additional Officers and Directors records available in full report.

Subsidiaries
Business Name Address City State/Province Country
F-Star Therapeutics Inc Eddeva B920, Babraham Research Campus CAMBRIDGE MA United Kingdom

Business Names
Business Name
1177
Chia Tai Medicines
F-Star Therapeutics Inc
4 additional Business Names available in full report.

General Information
Number of Employees: 25,806 (As of 12/31/2023)
Outstanding Shares: 18,801,217,230 (As of 12/31/2023)
Shareholders: 210,512
Stock Exchange: HKG
Fax Number: +852 28800847


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Friday, April 26, 2024